French pharmaceutical company Sanofi will increase its stockpile of drugs in the UK to ensure it has a 14-week supply, in case of disruption caused by a hard Brexit. Photograph: Fry said he was confident UK patients' medicine supply would not be disrupted. In June, AstraZeneca said it was increasing stocks by 20% in case of a hard Brexit.
French pharmaceutical company Sanofi will increase its stockpile of drugs in the UK to ensure it has a 14-week supply, in case of disruption caused by a hard Brexit. Hugo Fry, managing director, Sanofi UK, said the move was taken following recommendations from the European Federation of Pharmaceutical Industries and Associations, and Sanofi's own assessments, and had informed Health Secretary Matt Hancock. Fry said he was confident UK patients' medicine supply would not be disrupted. In June, AstraZeneca said it was increasing stocks by 20% in case of a hard Brexit.